C57BL/6N-Fustm2.1Ics/Ics

Status

Available to order

EMMA IDEM:16187
Citation informationRRID:IMSR_EM:16187 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameC57BL/6N-Fustm2.1Ics/Ics
Alternative nameFustm2.1Ics/Ics
Strain typeTargeted Mutant Strains : Conditional mutation
Allele/Transgene symbolFustm2.1Ics
Gene/Transgene symbolFus

Information from provider

ProviderLuc Dupuis
Provider affiliationCentre de Recherche en Biomédecine de Strasbourg (CRBS)
Genetic informationA loxP site was inserted into intron 12 and a second loxP site, an FRT site-flanked neomycin resistance gene cassette, a synthetic DNA fragment [consisting of last 254 bp of intron 12, fused exon 13 (ENSMUSE00001235788) and 14 (ENSMUSE00001215589) coding sequences and a STOP cassette (containing 3x SV40 poly(A) signal sequences)] were inserted downstream of the gene. The neo cassette was removed through subsequent flp-mediated recombination. This allele expresses the wild-type protein and only after cre-mediated deletion of the endogenous exons 13-15 it will express a protein lacking the NLS sequence, that is encoded by exon 15.
Phenotypic informationHomozygous:
N/A

Heterozygous:
N/A
Breeding historyC57BL/6N 0.07%, C57BL/6NCrl 62.50%, C57BL/6NTac 37.43%
References
  • Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss.;Scekic-Zahirovic Jelena, Sendscheid Oliver, El Oussini Hajer, Jambeau Mélanie, Sun Ying, Mersmann Sina, Wagner Marina, Dieterlé Stéphane, Sinniger Jérome, Dirrig-Grosch Sylvie, Drenner Kevin, Birling Marie-Christine, Qiu Jinsong, Zhou Yu, Li Hairi, Fu Xiang-Dong, Rouaux Caroline, Shelkovnikova Tatyana, Witting Anke, Ludolph Albert C, Kiefer Friedemann, Storkebaum Erik, Lagier-Tourenne Clotilde, Dupuis Luc, ;2016;The EMBO journal;35;1077-97; 26951610
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreICS, Institut Clinique de la Souris, Illkirch-Graffenstaden, France

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

IMPC phenotypes (gene matching)
  • increased respiratory quotient / IMPC
  • increased prepulse inhibition / IMPC
  • preweaning lethality, complete penetrance / IMPC
  • hypoplasia / IMPC
  • abnormal embryo size / IMPC
MGI phenotypes (gene matching)
  • small thymus / MGI
  • motor neuron degeneration / MGI
  • decreased motor neuron number / MGI
  • abnormal neuromuscular synapse morphology / MGI
  • small testis / MGI
  • decreased body weight / MGI
  • decreased body size / MGI
  • abnormal gait / MGI
  • abnormal suckling behavior / MGI
  • impaired limb coordination / MGI
  • increased mortality induced by gamma-irradiation / MGI
  • postnatal growth retardation / MGI
  • reduced female fertility / MGI
  • male infertility / MGI
  • decreased litter size / MGI
  • premature death / MGI
  • no abnormal phenotype detected / MGI
  • lymphoid hypoplasia / MGI
  • abnormal immunoglobulin level / MGI
  • no phenotypic analysis / MGI
  • abnormal chromosome morphology / MGI
  • aneuploidy / MGI
  • chromosome breakage / MGI
  • decreased lymphocyte cell number / MGI
  • decreased B cell number / MGI
  • abnormal male meiosis / MGI
  • abnormal hippocampus pyramidal cell morphology / MGI
  • postnatal lethality, incomplete penetrance / MGI
  • neonatal lethality, complete penetrance / MGI

Literature references

  • Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss.;Scekic-Zahirovic Jelena, Sendscheid Oliver, El Oussini Hajer, Jambeau Mélanie, Sun Ying, Mersmann Sina, Wagner Marina, Dieterlé Stéphane, Sinniger Jérome, Dirrig-Grosch Sylvie, Drenner Kevin, Birling Marie-Christine, Qiu Jinsong, Zhou Yu, Li Hairi, Fu Xiang-Dong, Rouaux Caroline, Shelkovnikova Tatyana, Witting Anke, Ludolph Albert C, Kiefer Friedemann, Storkebaum Erik, Lagier-Tourenne Clotilde, Dupuis Luc, ;2016;The EMBO journal;35;1077-97; 26951610

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).